News

The COVID-19 pandemic has revealed the importance of disease surveillance data for understanding the number of COVID-19 cases and deaths within communities, and how these

CHDS has awarded the 2020 Howard Raiffa Fund to health policy doctoral candidates John Giardina and Fangli Geng. Giardina’s project will focus on analyzing recent advances in personalized

Jamie Cohen, 5th year doctoral student in Decision Sciences/Health Policy, successfully defended her dissertation, Applications of Mathematical Modeling to Evaluate Cervical Cancer

Acute pulmonary embolism is a relatively common and serious medical condition, and there is some uncertainty around the optimal treatment choice. There are tradeoffs among ventricular

CHDS’s James Hammitt presented two seminars at Duke University. The first, “Fair Innings: The Utilitarian and Prioritarian Value of Risk Reduction over a Whole Lifetime,” describes

A new book, The Future of Risk Management, features a chapter by CHDS researcher Lisa A. Robinson and co-authors W. Kip Viscusi and Richard J. Zeckhauser on the problems associated with consumer

A Lancet Public Health article by CHDS researchers has resulted in numerous news outlets featuring the research. Emily Burger and Jane Kim have given interviews to Newsweek, Popular Science, Gizmodo,

The Immunization Costing Action Network (ICAN) team announced new and updated materials on immunization delivery costs in low-and middle-income countries (LMICs).

CHDS faculty James K. Hammitt is quoted in several recent articles on the value of reducing deaths from the COVID pandemic, including the Wall Street Journal, fivethirtyeight.com, and Forbes.

The Society for Risk Analysis recently featured a webinar, “Valuing Statistical Lives: Concepts, Current Practices, and Challenges,” led by CHDS researcher Lisa A. Robinson.